Companies / Kailera Therapeutics, Inc.

Kailera Therapeutics, Inc.

Nasdaq: KLRACIK 2096997WALTHAM, MA

Ownership

129.6M shares outstanding · as of Aug 6, 2026
0.03%Insiders
Ownership
Insiders0.03%38,094
10%+ / strategic20.25%26,255,581
Institutions3.09%4,008,165
Public float76.63%99,341,836

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 9

View all →
Insider% of sharesShares
20.25%26,255,581
Renaud Ronald C JRCEOCEO & President · Director
0.03%38,094

Institutional holders 6

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Apr 20, 2026Bain Capital Investors LLC
10% owner
BuyCommon Stock$134.38M+8.4M
+47.03%
26,255,581
20.25% of shares
high
Jun 9, 2026Renaud Ronald C JR
CEO
ExerciseCommon Stock$200.0K+38K
38,094
0.03% of shares
low
Jun 9, 2026Renaud Ronald C JR
CEO
ExerciseStock Option (right to buy)-38K
-4.45%
817,826
0.63% of shares
low
Apr 16, 2026Renaud Ronald C JR
CEO
GrantStock Option (right to buy)+300K
300,000
0.23% of shares
low
Apr 16, 2026Renaud Ronald C JR
CEO
GrantStock Option (right to buy)+300K
300,000
0.23% of shares
low
Apr 16, 2026Milligan John F
Director
GrantStock Option (right to buy)+38K
38,300
0.03% of shares
low
Apr 20, 2026Bain Capital Investors LLC
10% owner
OtherSeries B Preferred Stock-17.9M
-100.00%
0
0.00% of shares
low
Apr 20, 2026Bain Capital Investors LLC
10% owner
OtherCommon Stock+17.9M
17,857,143
13.77% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
KLRACommon StockEquity482931102BBG01Q3NQQJ1